You just read:

Encouraging Clinical Data From Multicenter Phase 1/2 Trial On Actinium's Actimab-A Presented At American Society Of Hematology Annual Meeting

News provided by

Actinium Pharmaceuticals, Inc.

Dec 09, 2013, 06:00 ET